Home / MissionIR Articles

MissionIR Articles

  • NovaBay Pharmaceuticals (NBY) Presents at Rodman & Renshaw Conference

    NovaBay Pharmaceuticals, Inc. (NYSE: NBY) is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. NovaBay has two distinct product categories:…

  • Northwest Biotherapeutics (NWBO) Presents at Rodman & Renshaw Conference

    Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) is developing cancer vaccines designed to treat a broad range of solid tumor cancers more efficiently and cost-effectively than current treatments, and without the side effects of chemotherapy drugs. The…

  • Nivalis Therapeutics (NVLS) Presents at Rodman & Renshaw Conference

    Boulder, Colorado-based Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is discovering solutions for cystic fibrosis. The company is developing a class of disease-modifying therapies designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell-signaling effects that…

  • NeuroMetrix (NURO) Presents at Rodman & Renshaw Conference

    NeuroMetrix, Inc. (NASDAQ: NURO) is an innovative health-care company developing wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders. Established in 1996 by Shai…

  • NephroGenex (NRX) Presents at Rodman & Renshaw Conference

    NephroGenex, Inc. (NASDAQ: NRX) is an innovator in the development of drugs to treat kidney disease with a first indication in diabetic nephropathy. It has been pioneering the development of PYRIDORIN (pyridoxaminedihydrochloride), a late stage…

  • NanoViricides (NNVC) Presents at Rodman & Renshaw Conference

    NanoViricides, Inc. (NYSE: NNVC) is a development stage company with a unique nanomedicine technology. The company is developing nanotechnology-based biomimetic anti-viral medicines called “nanoviricides.” So far, virus-specific nanoviricide drug candidates against five commercially important viral…

  • Nano Dimension (NNDMY) Presents at Rodman & Renshaw Conference

    Nano Dimension (OTC: NNDMY) was founded in 2012 and focuses on the research and development of advanced 3D electronics printing, including a printer for printing PCBs (printed circuit boards), and the development of nanotechnology- based…

  • Cleveland BioLabs (CBLI) Presents at Rodman & Renshaw Conference

    Cleveland BioLabs, Inc. (NASDAQ: CBLI), an innovative biopharmaceutical company, is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of toll-like immune receptor activators has applications in radiation…

  • MicroVision (MVIS) Presents at Rodman & Renshaw Conference

    MicroVision, Inc. (NASDAQ: MVIS) is a world leader in the innovation of a new generation of display technology. The company opens up a world of possibilities by bringing enhanced visibility to the world of mobility.…

  • Merus Labs International (MSLI) Presents at Rodman & Renshaw Conference

    Merus Labs International, Inc. (NASDAQ: MSLI) is on a quest to become a leading specialty pharmaceutical company with a diverse line of products in key global markets, with special geographic focus on North America and…

  • Medovex (MDVX) Presents at Rodman & Renshaw Conference

    Medovex Corporation (NASDAQ: MDVX) is a company dedicated to its mission of “better living through better medicine.” The highly successful and experienced healthcare executives at Medovex have a proven track record of building successful medical…

  • MDxHealth SA (MXDH) Presents at Rodman & Renshaw Conference

    MDxHealth SA (OTCBB: MXDH) is a multinational healthcare company that provides actionable epigenetic information to personalize the diagnosis and treatment of cancer.  The increased adoption of the company’s ConfirmMDx for Prostate Cancer testing solution within…

  • McEwen Mining (MUX) Presents at Rodman & Renshaw Conference

    McEwen Mining, Inc. (NYSE: MUX) is a growing gold and silver producer in the Americas. The company’s goal is to qualify for inclusion in the S&P 500. McEwen Mining’s principal assets include the following: interest…

  • MatinasBioPharma Holdings (MTNB) Presents at Rodman & Renshaw Conference

    MatinasBioPharma Holdings, Inc. (OTCQB: MTNB) is a clinical-stage biopharmaceutical company focused on identifying and developing safe and effective antifungal and anti-bacterial therapeutics for the treatment of serious and life-threatening infections. The company’s lead anti-infective product…

  • MagneGas (MNGA) Presents at Rodman & Renshaw Conference

    Tampa-based MagneGas Corporation (NASDAQ: MNGA) is a technology company that counts a patented process that converts liquid waste into hydrogen based fuels among its inventions. The company sells MagneGas into the metal working market as…

  • Liquidmetal Technologies (LQMT) Presents at Rodman & Renshaw Conference

    Liquidmetal Technologies, Inc. (OTCBB: LQMT) is a leading force in the research, development and commercialization of amorphous metals. The company’s revolutionary class of patented alloys and processes form the basis of high performance materials in…

  • LabStyle Innovations (DRIO) Presents at Rodman & Renshaw Conference

    LabStyle Innovations Corp. (OTC: DRIO) develops and commercializes patented technology providing consumers with laboratory-testing capabilities using smart mobile devices. LabStyle’s flagship product is the Dario™ Diabetes Management Solution. Dario™ empowers people with diabetes to take…

  • La Jolla Pharmaceutical Company (LJPC) Presents at Rodman & Renshaw Conference

    La Jolla Pharmaceutical Company (NASDAQ: LJPC) is focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The company has several product candidates in…

  • Kamada (KMDA) Presents at Rodman & Renshaw Conference

    KamadaLtd. (NASDAQ: KMDA) is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The company uses its proprietary platform technology and know-how for the…

  • Just Energy Group (JE) Presents at Rodman & Renshaw Conference

    Just Energy Group, Inc. (NYSE: JE) is an energy management solutions provider specializing in electricity, natural gas, solar and green energy. With offices located across the United States, Canada, and the United Kingdom, Just Energy…

  • iPass (IPAS) Presents at Rodman & Renshaw Conference

    iPass, Inc. (NASDAQ: IPAS) is a global Wi-Fi roaming market leader for enterprise employees and service provider subscribers. The company knits the world’s commercial Wi-Fi networks together to create a single global Wi-Fi network. With…

  • InVivo Therapeutics Holdings (NVIV) Presents at Rodman & Renshaw Conference

    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is on a quest to redefine the life of the spinal cord injury patient. Armed with cutting-edge technology and MIT science, experienced business and medical professionals at InVivo Therapeutics…

  • Inventergy Global (INVT) Presents at Rodman & Renshaw Conference

    Inventergy Global, Inc. (NASDAQ: INVT) is the brainchild of one of the intellectual property world’s most influential leaders, Joe Beyers. Having led global licensing for Hewlett-Packard for years, Beyers knew first-hand the challenges of leveraging…

  • Inuvo (INUV) Presents at Rodman & Renshaw Conference

    Inuvo, Inc. (NYSE: INUV) is an Internet marketing and technology company that delivers purchase-ready customers to advertisers through a broad network of desktop and mobile websites and app. The company has the opportunity to work…

  • International Stem Cell (ISCO) Presents at Rodman & Renshaw Conference

    International Stem Cell Corporation (OTCQB: ISCO) is a Montreal-based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery. Through its cutting edge formulation platforms, the company has developed a broad…

  • IntelGenx (IGXT) Presents at Rodman & Renshaw Conference

    IntelGenx (OTC: IGXT) is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company’s unique multiple layer delivery system provides zero-order release of…

  • InspireMD (NSPR) Presents at Rodman & Renshaw Conference

    InspireMD, Inc. (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio…

  • Inovio Pharmaceuticals (INO) Presents at Rodman & Renshaw Conference

    Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is on a quest to expand immune system stimulation to revolutionize the fight against cancers and infectious diseases. Stimulating the body’s immune system remains one of the most promising approaches…

  • Information Services Group (III) Presents at Rodman & Renshaw Conference

    Information Services Group, Inc. (NASDAQ: III) is a leading technology insights, market intelligence and advisory services company, serving more than 500 clients around the world to help them achieve operational excellence. ISG supports private and…

  • Immunomedics (IMMU) Presents at Rodman & Renshaw Conference

    Immunomedics, Inc. (NASDAQ: IMMU) is committed to being a leading, innovative biopharmaceutical company dedicated to improving a patient’s health and quality of life with novel antibody–based therapeutics for the treatment of cancer, autoimmune and other…

  • Immune Pharmaceuticals (IMNP) Presents at Rodman & Renshaw Conference

    Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, bertilimumab, is…

  • IDI (IDI) Presents at Rodman & Renshaw Conference

    IDI, Inc. (NYSE: IDI) is an information solutions provider focused on the data fusion market. IDI delivers otherwise unattainable insight into the ever-expanding universe of consumer- and business-centric data. Through proprietary linking technology, advanced systems…

  • I.D Systems (IDSY) Presents at Rodman & Renshaw Conference

    I.D. Systems, Inc. (NASDAQ: IDSY) has pioneered the use of RFID (radio frequency identification) technology for wireless vehicle management and fleet tracking. The initial success of I.D. Systems’ emerging technology came in 1995 when the…

  • Hydrogenics (HYGS) Presents at Rodman & Renshaw Conference

    Hydrogenics Corporation (NASDAQ: HYGS) has over 60 years of experience designing, manufacturing, building and installing industrial and commercial hydrogen systems around the globe. The company offers world-leading expertise for a range of applications, including: hydrogen…

  • Highpower International (HPJ) Presents at Rodman & Renshaw Conference

    Founded in 2001 and headquartered in Shenzhen, China, Highpower International, Inc. (NASDAQ: HPJ) specializes in clean energy storage. The company is focused on the development, manufacture and marketing of Ni-MH and lithium-ion rechargeable batteries, power…

  • Hemispherx Biopharma (HEB) Presents at Rodman & Renshaw Conference

    Hemispherx Biopharma, Inc. (NYSE: HEB) is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of viral and immune-based disorders. Hemispherx’s flagship products include Alferon N Injection and…

  • Hecla Mining Company (HL) Presents at Rodman & Renshaw Conference

    Hecla Mining Company (NYSE: HL) is the oldest precious metals mining company in North America. The company is not only the largest and one of the lowest-cost U.S. silver producers, but also a growing gold…

  • Heat Biologics (HTBX) Presents at Rodman & Renshaw Conference

    Heat Biologics, Inc. (NASDAQ: HTBX) is leading the immuno-oncology revolution. A clinical-stage company, Heat Biologics focuses on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell-based immunotherapy to treat patients with a…

  • Hansen Medical (HNSN) Presents at Rodman & Renshaw Conference

    Hansen Medical, Inc. (NASDAQ: HNSN), engaged in in intravascular robotics, is developing products and technology designed to enable the accurate positioning, manipulation and control of catheters and catheter-based technologies. The company’s Magellan™ Robotic System, Magellan…

  • Hansen Medical (HNSN) Presents at Rodman & Renshaw Conference

    Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, was born from the vision of creating a new generation of advanced medical robotics – a generation that would empower and protect physicians while…